For example, activators of pyruvate kinase (PKM2), the rate-limiting enzyme catalyzing the last step of glycolysis, have been shown to reduce the ROS-detoxification capacity of cancer cells and suppress tumor growth (Shahruzaman et al., 2018). This evidence concerns the gene PKM and cancer.